These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 19716393)

  • 1. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
    Pathania D; Millard M; Neamati N
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of cancer energy metabolism.
    Rodríguez-Enríquez S; Marín-Hernández A; Gallardo-Pérez JC; Carreño-Fuentes L; Moreno-Sánchez R
    Mol Nutr Food Res; 2009 Jan; 53(1):29-48. PubMed ID: 19123180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation of energy metabolism in breast cancer brain metastases.
    Chen EI; Hewel J; Krueger JS; Tiraby C; Weber MR; Kralli A; Becker K; Yates JR; Felding-Habermann B
    Cancer Res; 2007 Feb; 67(4):1472-86. PubMed ID: 17308085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria in cancer cells: what is so special about them?
    Gogvadze V; Orrenius S; Zhivotovsky B
    Trends Cell Biol; 2008 Apr; 18(4):165-73. PubMed ID: 18296052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria as targets for established and novel anti-cancer agents.
    Grad JM; Cepero E; Boise LH
    Drug Resist Updat; 2001 Apr; 4(2):85-91. PubMed ID: 11512525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell metabolism: cancer's Achilles' heel.
    Kroemer G; Pouyssegur J
    Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
    Moretti L; Yang ES; Kim KW; Lu B
    Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Moreno-Sánchez R
    Mol Aspects Med; 2010 Feb; 31(1):29-59. PubMed ID: 20026172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.
    Feron O
    Radiother Oncol; 2009 Sep; 92(3):329-33. PubMed ID: 19604589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting glucose metabolism: an emerging concept for anticancer therapy.
    Madhok BM; Yeluri S; Perry SL; Hughes TA; Jayne DG
    Am J Clin Oncol; 2011 Dec; 34(6):628-35. PubMed ID: 20805739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic targeting as an anticancer strategy: dawn of a new era?
    Pan JG; Mak TW
    Sci STKE; 2007 Apr; 2007(381):pe14. PubMed ID: 17426345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
    Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs targeting mitochondrial functions to control tumor cell growth.
    Dias N; Bailly C
    Biochem Pharmacol; 2005 Jul; 70(1):1-12. PubMed ID: 15907809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NADH-fumarate reductase system, a novel mitochondrial energy metabolism, is a new target for anticancer therapy in tumor microenvironments.
    Tomitsuka E; Kita K; Esumi H
    Ann N Y Acad Sci; 2010 Jul; 1201():44-9. PubMed ID: 20649538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative metabolism in cancer growth.
    Ristow M
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):339-45. PubMed ID: 16778561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells.
    Kluza J; Marchetti P; Gallego MA; Lancel S; Fournier C; Loyens A; Beauvillain JC; Bailly C
    Oncogene; 2004 Sep; 23(42):7018-30. PubMed ID: 15273722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue transglutaminase-mediated chemoresistance in cancer cells.
    Verma A; Mehta K
    Drug Resist Updat; 2007; 10(4-5):144-51. PubMed ID: 17662645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria: 3-bromopyruvate vs. mitochondria? A small molecule that attacks tumors by targeting their bioenergetic diversity.
    Galina A
    Int J Biochem Cell Biol; 2014 Sep; 54():266-71. PubMed ID: 24842108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial function and energy metabolism in cancer cells: past overview and future perspectives.
    Mayevsky A
    Mitochondrion; 2009 Jun; 9(3):165-79. PubMed ID: 19460294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria as targets for cancer chemotherapy.
    Gogvadze V; Orrenius S; Zhivotovsky B
    Semin Cancer Biol; 2009 Feb; 19(1):57-66. PubMed ID: 19101636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.